Developing anti-CD19 antibody-based combinations in lymphoma

被引：2
|
作者：
Kuruvilla, John [1 ]
机构：
[1] Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON M5G 2M9, Canada
来源：
LANCET ONCOLOGY | 2020年 / 21卷 / 07期
关键词：
D O I：
10.1016/S1470-2045(20)30275-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：870 / 872
页数：3
相关论文
共 50 条
  • [41] Cyclophosphamide inhibition of anti-CD40 monoclonal antibody-based therapy of B cell lymphoma is dependent on CD11b+ cells
    Honeychurch, J
    Glennie, LJ
    Illidge, TM
    CANCER RESEARCH, 2005, 65 (16) : 7493 - 7501
  • [42] Expression of a functional mouse-human chimeric anti-CD19 antibody in the milk of transgenic mice
    van Kuik-Romeijn, P
    de Groot, N
    Hooijberg, E
    de Boer, HA
    TRANSGENIC RESEARCH, 2000, 9 (02) : 155 - 159
  • [43] Immunomodulation of NK Cells through 4-1BB (CD137) to Improve the Anti-Lymphoma Activity of Rituximab: Antibody-Based Anti-Lymphoma
    Kohrt, Holbrook E.
    Houot, Roch
    Goldstein, Matthew J.
    Weiskopf, Kipp
    Chao, Mark
    Chen, Lieping
    Tedder, Thomas
    Levy, Ron
    BLOOD, 2010, 116 (21) : 188 - 189
  • [44] Case Report: Sustained Remission Achieved from Anti-CD19 CAR T Cell Therapy Despite Prior Treatment with Anti-CD19 Antibody Tafasitamab (MOR208) in a Patient with Relapsed and Refractory Diffuse Large B-Cell Lymphoma
    Oliai, Caspian
    de Vos, Sven
    BLOOD, 2019, 134
  • [45] EFFECT OF LIPOSOMES CONTAINING SODIUM-BUTYRATE CONJUGATED WITH ANTI-CD19 MONOCLONAL-ANTIBODY ON INVITRO AND INVIVO GROWTH OF MALIGNANT-LYMPHOMA
    WATANABE, M
    PESANDO, JM
    HAKOMORI, S
    CANCER RESEARCH, 1990, 50 (11) : 3245 - 3248
  • [46] Anti-CD19 CART cells for refractory myasthenia gravis
    Haghikia, Aiden
    Hegelmaier, Tobias
    Wolleschak, Denise
    Boettcher, Martin
    Desel, Christiane
    Borie, Dominic
    Motte, Jeremias
    Schett, Georg
    Schroers, Roland
    Gold, Ralf
    Mougiakakos, Dimitrios
    LANCET NEUROLOGY, 2023, 22 (12): : 1104 - 1105
  • [47] DLBCL Responds Well to Anti-CD19 CAR Therapy
    Rose, Suzanne
    CANCER DISCOVERY, 2017, 7 (03) : 241 - 242
  • [48] Gallic acid enhances anti-lymphoma function of anti-CD19 CAR-T cells in vitro and in vivo
    Luo, Zhiqiang
    Shi, Jiaru
    Jiang, Qiyao
    Yu, Guohua
    Li, Xiaorui
    Yu, Zhuoying
    Wang, Jianxun
    Shi, Yuanyuan
    MOLECULAR BIOMEDICINE, 2023, 4 (01):
  • [49] Anti-CD19 resistance can "stem" from progenitors
    Shah, Nirali N.
    Fry, Terry J.
    BLOOD, 2017, 130 (18) : 1961 - 1963
  • [50] Preclinical characterization of an auristatin-based anti-CD19 drug conjugate, SGN-19A
    Law, Che-Leung
    Sutherland, May
    Miyamoto, Jamie
    Hayes, Dawn
    Duniho, Steve
    Boursalian, Tamar
    Stone, Ivan
    Jonas, Mechthild
    Smith, Leia
    Benjamin, Dennis
    CANCER RESEARCH, 2011, 71
12345